MTOR and central nervous system cancer: For instance, the phosphatidylinositol 3‐kinase (PI3K)/Akt/rapamycin‐sensitive mTOR‐complex (mTOR) pathway is one of the key signaling pathways activated and affected in gliomas, and associated mutations can be found in most GB patients [46].